ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2026 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Cannabigerol Isolate

Also known as: CBG, Cannabigerol

Overview

Cannabigerol (CBG) is a non-psychoactive cannabinoid derived from the Cannabis sativa plant. Unlike other cannabinoids such as THC, CBG does not cause intoxication, positioning it as a viable therapeutic candidate in clinical applications. CBG is recognized for its potential therapeutic properties, specifically anti-inflammatory, antibacterial, and neuroprotective effects. As research progresses, CBG has captured the attention of scientific communities, though most studies have primarily been conducted in vitro or on animal models. Human clinical trials remain limited, underscoring a critical gap in knowledge around its efficacy, safety, and optimal usage. The importance of sourcing high-quality CBG supplements is also highlighted as preparation methods may influence its effects. CBG can be found in various forms, including oils, capsules, tinctures, and isolate powders.

Benefits

Evidence suggests that CBG offers several benefits, particularly its ability to inhibit cell proliferation in breast cancer cell lines and potentially induce necroptosis, a form of programmed cell death. Additionally, CBG exhibits robust anti-inflammatory and antibacterial properties, making it relevant in managing conditions associated with chronic inflammation and bacterial infections. Preclinical studies indicate that CBG may confer neuroprotection, potentially benefitting those with neurodegenerative disorders such as Huntington's disease. However, most benefits are derived from studies lacking rigorous human clinical data, which limits definitive conclusions regarding efficacy. Future human trials are essential for establishing the clinical significance and potential treatments for specific populations.

How it works

CBG primarily interacts with the endocannabinoid system by binding to CB1 and CB2 receptors, which are pivotal in modulating bodily functions such as inflammation, pain, and neurotransmission. Additionally, CBG influences other signaling pathways, including the TRP channels and α2-adrenoceptors, which further govern physiological reactions and cellular responses. These interactions can potentially lead to reduced inflammation and protection against neurodegeneration. Despite these findings, detailed information on absorption and bioavailability in humans remains limited, necessitating further research.

Side effects

CBG is generally viewed as safe; however, due to insufficient human clinical data, common side effects remain poorly documented. Some anecdotal reports suggest gastrointestinal issues may arise, a common concern associated with cannabinoids. Rare side effects are not well-established, but the lack of extensive human trials raises caution regarding unreported adverse effects. Potential drug interactions, particularly with medications metabolized by CYP450 enzymes, warrant careful consideration, although specific data is lacking. Pregnant and breastfeeding individuals should exercise caution given the limited data on CBG's safety profile in these populations. Further, specific risk factors related to age (children and elderly) or severe medical conditions require additional study.

Dosage

Effective dosage guidelines for CBG are not established in humans, as most experimental data derive from animal studies. While preliminary research has evaluated a range of dosages, broad consensus on minimum effective doses remains elusive. Optimal dosages need to be clarified, and current recommendations range widely based on preliminary findings. The maximum safe dose is also undetermined, emphasizing the need for caution. There are no established guidelines regarding timing or form-specific recommendations, as data on absorption factors is similarly lacking. Safety thresholds and required cofactors remain to be elucidated through forthcoming clinical trials.

FAQs

Is CBG safe for human consumption?

While CBG is generally considered safe, limited human studies complicate safety assurances across various populations.

What are the potential effects of CBG?

CBG may provide potential anti-inflammatory and neuroprotective benefits, but more research is necessary to substantiate these claims in humans.

How long does it take to feel the effects of CBG?

The time course for experiencing benefits from CBG is unclear due to the lack of comprehensive human studies.

Can I use CBG along with other supplements or medications?

Caution is advised as CBG may interact with medications metabolized by CYP450 enzymes; consulting with a healthcare professional is recommended.

Does CBG cause intoxication?

No, CBG is non-psychoactive and does not induce intoxication, differing significantly from THC.

Research Sources

  • https://www.researchgate.net/publication/386004381_Cannabigerol_CBG_A_Comprehensive_Review_of_Its_Molecular_Mechanisms_and_Therapeutic_Potential – This comprehensive review examines CBG's molecular mechanisms, highlighting its anti-inflammatory and neuroprotective properties while stressing the need for more clinical research to validate efficacy.
  • https://pubmed.ncbi.nlm.nih.gov/39598860/?fc=None&ff=20241211143624&v=2.18.0.post9+e462414 – This meta-analysis explores the effects of CBG on breast cancer tissue cells, indicating its potential for reducing proliferation and inducing necroptosis, though primarily based on in vitro studies.
  • https://pubmed.ncbi.nlm.nih.gov/35887277/ – This umbrella review highlights the necessity for rigorous clinical trials across cannabinoid research, emphasizing evidence gaps in evaluating efficacy and safety for human subjects.

Supplements Containing Cannabigerol Isolate

Uplift CBG + CBD Oil by Bluebird Botanicals
70

Uplift CBG + CBD Oil

Bluebird Botanicals

Score: 70/100

Recommended Articles

Top CBD Brands with 2025 Batch COAs & Profiles

Top CBD Brands with 2025 Batch COAs & Profiles

Select CBD brands offer comprehensive 2025 batch COAs and detailed cannabinoid profiles, ensuring product quality and safety.